Cryoport Inc

CYRX remains in a Stage 2 advancing uptrend with sequential higher highs and higher lows, and medium-term structure is firmly bullish. Price is currently holding just above the rising 9 and 21 EMAs, offering a supportive pullback into the EMA zone. Short-term execution conditions are favorable for engaging now on this pullback. We will Buy Now into the rising EMA support area to align with the established bullish trend.

• ↑Q1’26 revenue $47.8M (+16% YoY), cell and gene therapy sales $9.1M (+26%)
• ↑Raised FY2026 revenue guidance to $192–196M
• ↓Negative 0.79 earnings yield flags profitability challenges